U.S. Physical Therapy, Inc. Common Stock (USPH)

81.18
-0.56 (-0.69%)
NYSE· Last Trade: Aug 11th, 2:17 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
1 Russell 2000 Stock Worth Investigating and 2 We Brush Off
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via StockStory · August 10, 2026
U.S. Physical Therapy Q2 Earnings Call Highlightsmarketbeat.com
U.S. Physical Therapy (NYSE:USPH) reported second-quarter 2026 revenue growth supported by higher patient volumes, improved reimbursement rates and the early rollout of hospital-affiliation agreements, while elevated employee healthcare claims and upfront staffing costs pressured physical therapy ma
Via MarketBeat · August 9, 2026
Why U.S. Physical Therapy (USPH) Shares Are Trading Lower Today
What Happened? Shares of outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) fell 2.1% in the afternoon session after the company reported...
Via StockStory · August 6, 2026
U.S. Physical Therapy (NYSE:USPH) Misses on EPS, Reaffirms Full-Year Guidancechartmill.com
Via Chartmill · August 5, 2026
Earnings To Watch: U.S. Physical Therapy (USPH) Reports Q2 Results Tomorrow
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) will be reporting earnings this Wednesday after the bell. Here’s what to look for. U.S...
Via StockStory · August 3, 2026
U.S. Physical Therapy Inc. (NYSE:USPH) Shares Dip 4.2% on Q1 Earnings Miss Despite Record Revenuechartmill.com
Via Chartmill · May 6, 2026
3 Healthcare Stocks We Find Risky
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...
Via StockStory · July 30, 2026
1 Profitable Stock Worth Your Attention and 2 We Avoid
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · July 16, 2026
Outpatient & Specialty Care Stocks Q1 Highlights: U.S. Physical Therapy (NYSE:USPH)
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at U.S. Physical Therapy (NYSE:U...
Via StockStory · July 12, 2026
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via StockStory · June 19, 2026
1 Cash-Producing Stock Worth Investigating and 2 We Turn Down
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · June 17, 2026
3 Reasons USPH is Risky and 1 Stock to Buy Instead
U.S. Physical Therapy currently trades at $65.04 per share and has shown little upside over the past six months, posting a small loss of 4.3%. The stock also...
Via StockStory · May 19, 2026
Stocks making big moves yesterday: Helios, DraftKings, CACI, U.S. Physical Therapy, and Ulta
Check out the companies making headlines yesterday: Helios (NYSE:HLIO): Motion control and electronic systems manufacturer Helios Technologies (NYSE:HLIO) ro...
Via StockStory · May 13, 2026
U.S. Physical Therapy’s Q1 Earnings Call: Our Top 5 Analyst Questions
U.S. Physical Therapy’s first quarter results were met with a sharp negative market reaction, reflecting investor concerns over margin compression and profit...
Via StockStory · May 13, 2026
U.S. Physical Therapy (USPH) Stock Is Up, What You Need To Know
What Happened? Shares of outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) jumped 4.4% in the afternoon session after the stock continue...
Via StockStory · May 12, 2026
USPH Q1 Deep Dive: Margin Pressures and Growth Initiatives Amid Volume Growth
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.9% year on year t...
Via StockStory · May 7, 2026
USPH Q1 2026 Earnings Call Transcriptfool.com
USPH Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 7, 2026
U.S. Physical Therapy’s (NYSE:USPH) Q1 CY2026 Earnings Results: Revenue In Line With Expectations
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.9% year on year t...
Via StockStory · May 6, 2026
U.S. Physical Therapy (USPH) Q1 Earnings: What To Expect
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) will be reporting earnings this Wednesday after market close. Here’s what to look for....
Via StockStory · May 4, 2026
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · April 24, 2026
3 of Wall Street’s Favorite Stocks with Open Questions
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via StockStory · April 17, 2026
1 Healthcare Stock on Our Watchlist and 2 We Avoid
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...
Via StockStory · April 9, 2026
3 Reasons to Sell USPH and 1 Stock to Buy Instead
Although the S&P 500 is down 3.2% over the past six months, U.S. Physical Therapy’s stock price has fallen further to $74.73, losing shareholders 12% of thei...
Via StockStory · March 30, 2026
3 Profitable Stocks We Approach with Caution
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · March 27, 2026
1 Russell 2000 Stock with Exciting Potential and 2 We Avoid
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...
Via StockStory · March 5, 2026